Cerity Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $153M | Buy |
433,555
+21,682
| +5% | +$7.73M | 0.22% | 95 |
|
|
2025
Q4 | $135M | Sell |
411,873
-4,309
| -1% | -$1.37M | 0.2% | 100 |
|
|
2025
Q3 | $117M | Sell |
416,182
-6,837
| -2% | -$1.98M | 0.19% | 111 |
|
|
2025
Q2 | $118M | Buy |
423,019
+16,972
| +4% | +$4.81M | 0.21% | 99 |
|
|
2025
Q1 | $127M | Buy |
406,047
+16,909
| +4% | +$4.99M | 0.26% | 85 |
|
|
2024
Q4 | $107M | Sell |
389,138
-6,135
| -2% | -$1.82M | 0.23% | 90 |
|
|
2024
Q3 | $127M | Buy |
395,273
+50,034
| +14% | +$16.4M | 0.28% | 74 |
|
|
2024
Q2 | $108M | Sell |
345,239
-37,740
| -10% | -$11.1M | 0.28% | 72 |
|
|
2024
Q1 | $108M | Buy |
382,979
+116,554
| +44% | +$34.1M | 0.29% | 72 |
|
|
2023
Q4 | $76.7M | Buy |
266,425
+23,420
| +10% | +$6.38M | 0.25% | 93 |
|
|
2023
Q3 | $65.3M | Sell |
243,005
-37,221
| -13% | -$9.29M | 0.32% | 83 |
|
|
2023
Q2 | $62.2M | Buy |
280,226
+45,720
| +19% | +$10.6M | 0.24% | 96 |
|
|
2023
Q1 | $153M | Buy |
234,506
+41,976
| +22% | +$10.3M | 0.36% | 40 |
|
|
2022
Q4 | $51.6M | Buy |
192,530
+104,702
| +119% | +$28.1M | 0.33% | 74 |
|
|
2022
Q3 | $19.8M | Buy |
87,828
+445
| +0.5% | +$108K | 0.24% | 88 |
|
|
2022
Q2 | $21.3M | Buy |
87,383
+51,555
| +144% | +$12.6M | 0.24% | 91 |
|
|
2022
Q1 | $7.8M | Buy |
35,828
+2,674
| +8% | +$614K | 0.12% | 147 |
|
|
2021
Q4 | $6.66M | Buy |
33,154
+7,511
| +29% | +$1.59M | 0.1% | 168 |
|
|
2021
Q3 | $5.45M | Buy |
25,643
+3,714
| +17% | +$855K | 0.12% | 152 |
|
|
2021
Q2 | $5.34M | Buy |
21,929
+240
| +1% | +$59K | 0.12% | 155 |
|
|
2021
Q1 | $5.4M | Sell |
21,689
-1,882
| -8% | -$449K | 0.13% | 142 |
|
|
2020
Q4 | $5.42M | Buy |
23,571
+977
| +4% | +$225K | 0.17% | 117 |
|
|
2020
Q3 | $5.74M | Buy |
22,594
+4,208
| +23% | +$1.04M | 0.24% | 85 |
|
|
2020
Q2 | $4.34M | Buy |
18,386
+772
| +4% | +$176K | 0.24% | 88 |
|
|
2020
Q1 | $3.57M | Buy |
17,614
+867
| +5% | +$189K | 0.22% | 85 |
|
|
2019
Q4 | $4.04M | Buy |
16,747
+259
| +2% | +$57.1K | 0.21% | 93 |
|
|
2019
Q3 | $3.19M | Buy |
16,488
+2,756
| +20% | +$529K | 0.19% | 120 |
|
|
2019
Q2 | $2.53M | Sell |
13,732
-5,072
| -27% | -$908K | 0.16% | 130 |
|
|
2019
Q1 | $3.57M | Sell |
18,804
-3,621
| -16% | -$691K | 0.24% | 87 |
|
|
2018
Q4 | $4.37M | Buy |
22,425
+1,205
| +6% | +$235K | 0.29% | 77 |
|
|
2018
Q3 | $4.4M | Buy |
21,220
+190
| +0.9% | +$37.4K | 0.3% | 82 |
|
|
2018
Q2 | $3.88M | Sell |
21,030
-1,408
| -6% | -$249K | 0.29% | 91 |
|
|
2018
Q1 | $3.83M | Sell |
22,438
-1,181
| -5% | -$217K | 0.29% | 88 |
|
|
2017
Q4 | $4.11M | Buy |
23,619
+253
| +1% | +$44.8K | 0.28% | 85 |
|
|
2017
Q3 | $4.36M | Buy |
23,366
+18,911
| +424% | +$3.35M | 0.31% | 74 |
|
|
2017
Q2 | $270K | Sell |
4,455
-14,992
| -77% | -$2.44M | 0.02% | 305 |
|
|
2017
Q1 | $3.19M | Buy |
19,447
+17,954
| +1,203% | +$2.98M | 0.27% | 73 |
|
|
2016
Q4 | $218K | Buy |
+1,493
| New | +$225K | 0.3% | 48 |
|
Other funds holding AMGN
VCM
VPM
Cerity Partners's AMGN Position: Q1 2026 in Review
Cerity Partners increased its Amgen (AMGN) stake by 5.3% in Q1 2026, buying an estimated $7.73M and bringing the position to 433,555 shares worth $153M. The position accounts for 0.22% of the portfolio, ranked #95.
Cerity Partners first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. The position peaked at $153M in Q1 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Cerity Partners held 433,555 shares of Amgen worth $153M as of Q1 2026.
- Cerity Partners bought 21,682 Amgen shares in Q1 2026, an estimated $7.73M.
- Amgen made up 0.22% of Cerity Partners's portfolio in Q1 2026, its #95 holding.
- Cerity Partners first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- Cerity Partners's Amgen position peaked at $153M in Q1 2023.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.